Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis

  title={Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis},
  author={Alexander Tsertsvadze and H. Fink and F. Yazdi and R. MacDonald and A. Bella and M. Ansari and C. Garritty and K. Soares-Weiser and R. Daniel and M. Sampson and S. Fox and D. Moher and T. J. Wilt},
  journal={Annals of Internal Medicine},
  • Alexander Tsertsvadze, H. Fink, +10 authors T. J. Wilt
  • Published 2009
  • Medicine
  • Annals of Internal Medicine
  • Erectile dysfunction (ED) is a common male sexual disorder and is defined as the persistent inability to achieve or maintain penile erection sufficient for satisfactory sexual performance (1). Advanced age, diabetes, vascular diseases, psychiatric disorders, and possibly hypogonadism are associated with increased prevalence of ED (14). According to data from the Massachusetts Male Aging Study (2), the prevalence of ED in men aged 40 to 70 years is about 50%. Unless contraindicated, oral… CONTINUE READING
    254 Citations
    An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors
    • 75
    • PDF
    Focus on phosphodiesterase inhibitors for the treatment of erectile dysfunction in older men.
    • M. Lee
    • Medicine
    • Clinical therapeutics
    • 2011
    • 10
    Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.
    • 61
    • PDF
    A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction
    • 7
    A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
    • 29
    • Highly Influenced
    • PDF
    Current Diagnosis and Management of Erectile Dysfunction
    • 38
    The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction
    • 8
    • PDF


    Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
    • 72
    Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men
    • 112
    The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction.
    • 66
    • PDF
    • Arin, ADMA, +4 authors OSEN
    • 2000
    • 931
    • PDF
    Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction.
    • 11
    • PDF
    Sildenafil citrate (Viagra) is effective and well tolerated for treating erectile dysfunction of psychogenic or mixed aetiology.
    • 45